Preferred Pharmaceuticals, Inc. has recalled Losartan Potassium and hydrochlorothiazide (HCTZ) 50mg/12.5 mg tablets because they contain an AZIDO impurity above acceptable safety limits. The recall affects 78 units, consisting of 31 bottles of 90 tablets (Lot: K1721D), 5 bottles of 90 tablets (K1021E), 47 Bottles of 30 Tabs (K1721E), and 35 Bottles of 30 Tabs (H3021Q). AZIDO is a chemical compound that can potentially increase the risk of cancer over long-term exposure. No injuries or illnesses have been reported to date regarding this recall.
The medication was found to contain levels of an AZIDO impurity that exceed the FDA's acceptable safety thresholds. While there is no immediate acute health risk, long-term exposure to this impurity is associated with an increased risk of developing cancer.
You have 2 options:
31 bottles of lot K1721D and 5 bottles of lot K1021E affected.
47 bottles of lot K1721E and 35 bottles of lot H3021Q affected.
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.